✦ LIBER ✦

Warfarin therapy is feasible in CYP2C9*3 homozygous patients

✍ Scribed by Jacob Ablin; Shaltiel Cabili; Amiram Eldor; Ayala Lagziel; Hava Peretz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O94 Feasibility of warfarin therapy in c

✍ J. Ablin; A. Eldor; H. Peretz; A. Lagziel; S. Cabili 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 122 KB

CYP2C19 Polymorphism in Korean patients

✍ Sukhyang Lee; Hyun Jin Hwang; Jae-Moon Kim; Chin-Sang Chung; Jeong Hee Kim 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 672 KB

Standard warfarin dose in a patient with

✍ Toshiharu Goto; Masatomo Miura; Atsunobu Murata; Ken Terata; Tsukasa Uno; Koujir 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 188 KB

CYP2C9genotypes and the quality of antic

✍ M. V. Lima; G. S. Ribeiro; E. T. Mesquita; P. R. Victer; R. Vianna-Jorge 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 150 KB

Low dose requirement for warfarin treatm

✍ Min-Jung Kwon; Young-Keun On; Wooseong Huh; Jae-Wook Ko; Duk-Kyung Kim; June Soo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 237 KB

First report of warfarin dose requiremen

✍ O'Brien, Travis J.; Kidd, Robert S.; Richard, Craig A.H.; Ha, Ngoc-Han; Witcher, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 546 KB